EU and US to co-ordinate funding of orphan drug trials
This article was originally published in SRA
Executive Summary
The EU and the US are to co-operate on the funding of research into rare diseases, including co-ordinated clinical trials of promising new orphan drugs, with the aim of accelerating medical breakthroughs for people with rare diseases1.